Epstein-Barr virus associated polymorphic lymphoproliferative disorders occurring in nontransplant settings

Laboratory Investigation

Volumn 81, Issue 4, 2001, Pages 429-437

  Tao, Jianguo ^a   Wasik, Mariusz A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

ADOLESCENT; ADULT; CELL CYCLE; CHILD; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; FIBROBLAST; GENE EXPRESSION; HISTIOCYTE; HUMAN; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS CELL TRANSFORMATION;

CELL TRANSFORMATION, VIRAL; CYTOKINES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; MODELS, BIOLOGICAL; ORGAN TRANSPLANTATION; SIGNAL TRANSDUCTION; VIRUS LATENCY;

EID: 0035050827     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780251     Document Type: Review

References (82)

1. Association of EBV with Hodgkin's disease
2. Epstein-Barr virus in tumors
3. Control of apoptosis by REL/NF-κB transcription factors
4. Favored use of immunoglobulin VH4 genes in AIDS-associated B-cell lymphomas
5. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease
6. HIV-associated Hodgkin's disease derives from post-germinal center B-cells
7. In situ hybridization methodology for the detection of EBV EBER-1, RNA in paraffin-embedded tissue, as applied to normal and neoplastic tissue
8. EBV and immune system: Hide and seek
9. Epstein-Barr virus infection
10. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocytes transformation
11. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancer
12. Acute and chronic inflammation
13. Lymphomas in the immunocompromised patient
14. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
15. EBV LMP-1 activates the JNK pathway through its extreme C-terminus via a mechanism involving TRADD and TRAF2
16. Activation of the p38 mitogen activated protein kinase pathway by EBV LMP1 coregulates IL-6 and IL-8 production
17. Activation of the cJun N-terminal kinase (JNK) pathway by EBV LMP-1
18. IL-6 production in high-grade B lymphomas: Correlation with the presence of malignant immunoblasts in AIDS and HIV negative patients
19. Production and roles of IL-6, IL-10, and IL-13 in B-cell malignancies and in B-cell hyperactivity of HIV-infection and autoimmunity
20. TNF-induced VCAM expression is mitogen-activated protein kinase (MAPK) dependent
21. Hypercytokinemia in hemophagocytic syndrome
22. The molecular basis of AIDS-related lymphomagenesis
23. Pathogenesis of AIDS-related lymphomas: Molecular and histogenetic heterogeneity
24. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
25. Pulmonary lymphomatoid granulomatosis. Evidence of EBV infected B-lymphocytes with a prominent T-cell component and vasculitis
26. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: Prophylactic infusion of EBV-specific cytotoxic T cells
27. EBV induced polyclonal and monoclonal B-cell lymphoproliferative disorders occurring after renal transplantation: Clinical, pathologic, and virologic findings and implications for therapy
28. Mediation of Epstein-Barr virus EBNV2 transactivation by recombination signal-binding protein J kappa
29. Frequent expression of IL-10 by EBV-harboring tumor cells of Hodgkin's disease
30. High prevalence of EBV genome detection in Hodgkin's disease
31. IL-6 is essential for in vivo development of B-cell lineage neoplasmas
32. The EBV latent membrane protein-1 (LMP-1) mediate activation of NF-kappa B and cell surface phenotype via two effector region in its carboxy-terminal domain
33. Immunoglobin V genes in Reed-Sternberg cells
34. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas: Lessons learned composite and sequential malignancies
35. A potential role for antigen selection in the clonal evolution of Burkitt's lymlignancies
36. Latrogenic lymphoproliferative disorders in nontransplantation settings
37. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term, low-dose methotrexate therapy
38. Hodgkin and Reed-Sternberg cells in Hodgkin disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B-cells
39. EBV-associated disease in human
40. EBV latent membrane protein-1 is essential for B-lymphocyte growth transformamation
41. Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
42. Epstein-Barr virus and its replication
43. Low-grade monoclonal EBV-associated lymphoproliferative disorder of the brain presenting as HIV-associated encephalopathy in a child with AIDS
44. Immunodeficiency-associated lymphoproliferative disorders
45. NF-κB and Rel proteins in innate immunity
46. The origin of Hodgkin and Reed-Sternberg cells in Hodgkin's disease
47. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development
48. JAKS and STATS: Biological implications
49. EBV and a cellular signaling pathway in lymphomas from immunosuppressed patients
50. The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders
51. IL-10 is an autocrine growth factor for AIDS-related B-cell lymphoma
52. Lymphokine gene expression and effects on cell proliferation and effects on cell proliferation in AIDS-associated NHL
53. Angiocentric immunoproliferative lesions: A molecular analysis of eight cases
54. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
55. AIDS-related polymorphic lymphoproliferative disorders
56. Treatment of Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder with foscarnet alone in an adult after simultaneous heart and renal transplantation
57. SHP-1 expression indicates the post-germinal center cell derivation of posttransplant lymphoproliferative disorders (PTDs)
58. Epstein-Barr virus
59. Hodgkin's disease associated with HIV infection
60. Virostatic therapy for advanced lymphoproliferation associated with the Epstein-Barr virus in an HIV-infected patient
61. EBV-associated non-Hodgkin's lymphoma in patients infected with HIV
62. Detection of EBV in transformations of low-grade B-cell lymphomas after fludarabine treatment
63. HIV-associated Hodgkin's disease
64. EBV upregulates TNF-α gene expression in T-cell lymphomas: Implications for pathogenesis of EBV-associated hemophagocytic syndrome
65. Transplantation-related lymphoproliferative disorder: A model for HIV-related lymphoma
66. TNF- and thrombin-induced VCAM, CD54 and E-selectin expression is mitogen-activated protein kinase (MAPK) dependent
67. Epstein-Barr virus (EBV) associated high-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) involving lungs, kidneys and axillary lymph node in a 9-year-old boy
68. Aggressive natural killer (NK) cell lymphoma presenting as anterior mediastinal mass in a patient with acquired immune deficiency syndrome
69. Polymorphic lymphoproliferative disorders in the lungs of children with acquired immunodeficiency syndrome: A report of two cases
70. Epstein-Barr virus-associated polymorphic lymphoproliferative disorders (EBV-LD) in patients with different underlying immunodeficiency states. A molecular analysis and clinical-pathologic correlation study of 12 cases
71. Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of EBV tumorigenesis in Burkitt's lymphoma
72. NF-κB: A lesion in family values
73. Epstein-Barr virus and lymphoproliferation in methotrexate treated rheumatoid arthritis
74. Hodgkin's disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states
75. IL-6 production in post-transplant lymphoproliferative disease
76. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cell
77. EBV latent membrane protein (LMP)-1 and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP-1 cooperatively induce CD23
78. Frequency of EBVDNA in "Western" sinonasal and Waldeyer's ring lymphoma
79. EBV DNA in tissues of Hodgkin's disease
80. EBV-immortalized B-cells produce IL-6 as an autocrine growth factor
81. EBV-associated lymphoma in a patient with rheumatoid arthritis treated with cyclosporine
82. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease